In December 2024 , the FDA determined that AOD-9604 (both free base and acetate forms) should not be included on the 503A Bulks List for pharmaceutical compounding, citing concerns over limited long-term safety data, peptide impurities, and potential immunogenicity
While the Daily Replenisher is free from many common allergens, individual sensitivities to specific ingredients like ashwagandha (which can affect thyroid function) or BioPerine (which can interact with certain medications) should be discussed with a healthcare provider
Dermal melasma is the most challenging category and requires the most realistic expectations
FDA-approved under the brand name Mounjaro for type 2 diabetes and as Zepbound for chronic weight management, tirzepatide addresses a spectrum of conditions that go far beyond the number on the scale
What to know about various ways to boost your energy through diet and feel more rested.
B12 shots altogether bypass any absorption issues in the gut